Page 151 - CW E-Magazine (1-4-2025)

Pharmaceuticals Fertilisers

PARTNERSHIP PROJECT PROGRESS
Alembic Pharma joins up with Amlan on poultry Union Cabinet approves Rs. 10,601-crore for Namrup

health solutions IV fertiliser plant

Alembic Pharmaceuticals and Mr. P. Karunanithi, Executive Vice The Union Cabinet has approved Rs. 30,116 per metric tonne of urea. a nomination basis through a joint
Amlan International, the animal health President (Cluster Head), Animal Rs. 10,601-crore for the new brown The project is scheduled for comple- venture, with a debt-equity ratio of
business of Oil-Dri Corporation of Health Division at Alembic Pharma- fi eld ammonia-urea complex Namrup tion within 48 months. The existing 70:30 (Rs. 7,421-crore debt and
America, have entered into a strategic ceuticals, said, “Poultry production IV fertiliser plant with a projected Namrup III plant has been operational Rs. 3,180.40-crore equity). The approved
commercial agreement to introduce effi ciency starts with a healthy in- annual capacity of 12.7-lakh metric for 33 years and recently received equity pattern included: Government
poultry health solutions in India. testinal environment. By integrating tonnes (lmt). Rs. 100-crore as grant-in-aid for the of Assam (40% - Rs. 1,272-crore, with
Amlan’s innovative feed additive modernisation of key components, in-principle approval), BVFCL (11%
This collaboration will expand technologies into our portfolio, we Commenting on the development, thereby extending its economic life by an in lieu of tangible assets), Hindustan
access to advanced feed additives that Mr. Shaunak Amin, Managing Direc- are strengthening our commitment to the Union Minister of Ports, Shipping & additional fi ve years. Urvarak & Rasayan Ltd. (13% –
improve gut health, nutrient absorp- tor, Alembic Pharmaceuticals, said the delivering science-backed solutions Waterways (MoPSW), Mr. Sarbananda Rs. 413.45-crore), National Fertilizers Ltd.
tion, and feed conversion ratios (FCR), partnership allowed it to bring scienti- that enhance poultry health and per- Sonowal, said, “With no other ammonia- Out of the 349 hectares complex of (18% - Rs. 572.47-crore), and Oil India
ensuring better poultry yields and fi cally backed, practical solutions to formance.” urea plant in the Northeast, this initiative Brahmaputra Valley Fertilizer Corpora- Ltd. (18% - Rs. 572.47-crore). BVFCL’s
supporting the industry’s growing de- poultry farmers across India. “With will reduce transportation costs, secure tion Ltd. (BVFCL), the newly approved equity contribution was through the
mand for high-quality protein, a joint Amlan’s expertise in toxin binder and Oil-Dri Corporation of America is future demand, and generate direct and Namrup IV plant will come up in 172 transfer of tangible assets to the JV.
statement informed. It also establishes gut health and with our strong presence a global company involved with indirect employment, while leveraging hectares. The new plant has a require-
a framework for knowledge sharing, in the market, we’re not just introduc- sorbent mineral technology and over 80 Assam’s natural gas resources and ment of 2.35-mmscmd of natural gas. Currently, there are 33 operational
technical training, and sustainable ing new products, we’re addressing key years of expertise in mineral science, proximity to neighbouring markets like Out of this, 0.62-mmscmd is available urea units across the country, with a
growth in India’s poultry sector. challenges in poultry farming,” he said. the note said. Myanmar, Bangladesh, and Bhutan.” on fall-back basis and rest 1.73-mmsc- total production of 314.09-lakh metric
md will be made available from the tonnes in 2023-24. However, with an
Eli Lilly launches weight-loss drug in India The project boasts a competitive National Gas Grid. actual consumption of 357.26-lmt, a
post-tax Internal Rate of Return (IRR) supply-demand gap of 70.42-lmt is
The much-awaited weight-loss and Priced at Rs. 3,500 for a 2.5-mg vial The drug activates both GIP of 10.19% and a realisation price of The project was sanctioned on being met through imports.
diabetes drug, Mounjaro from US- and Rs. 4,375 for a 5-mg vial, a com- (glucose-dependent insulinotropic poly-
based Eli Lilly and Company will be pany spokesperson said the “India-spe- peptide) and GLP-1 (glucagon-like pep- REDUCING IMPORT DEPENDENCY
available at local chemists in a few cifi c pricing” refl ected Lilly’s commit- tide-1) hormone receptors, it added.
weeks, at an India-specifi c price. ment to expanding access to innovative Both Eli Lilly and Novo Nordisk have India set to kick off local potash mining
treatments in the country. been taking their respective popular inject-
Globally Mounjaro, and peers in this able brands, Mounjaro (Tirzepatide) and
India imported potassium chloride
India is likely to award its fi rst tional, this will help reduce import
category, Ozempic/Wegovy from Novo Mounjaro is a once-a-week, pre- Ozempic/Wegovy (semaglutide), to more potash blocks in the coming months under dependence,” a senior offi cial was quot- worth Rs. 8,054.83-crore in the
Nordisk, are popular for their “weight- scription-based medicine that reduces countries. The oral version of sema- a dedicated policy to extract critical ed as saying in the report. The auction fi rst nine months of 2024-25.
loss” features, and diabetologists say, food intake, body weight, and decreases glutide (Novo Nordisk) is available in minerals in the country, according to a of these mines has been made possible Russia and Canada were the top
patients with obesity and type- 2 diabe- fat mass by regulating appetite and has India, an injectable version is awaited. report in the Economic Times. This will after the government relaxed bid condi- suppliers of the raw material to
tes have been keen to access these drugs been demonstrated to regulate lipid Oral semaglutide costs a person living be the fi rst time that this crucial feed- tions to allow for a more liberalised India during the period under re-
locally. utilisation, a note from Lilly said. with diabetes about Rs. 10,000 a month.
stock for fertiliser production will be minimum net worth criterion. view. Souring of diplomatic relations
with Canada is said to have triggered a
Zydus Lifesciences gets USFDA nod to produce mined in the country. The mines ministry is currently change in India’s potash import trends.
India imports its entire potash auctioning the Jhandawali-Satipura India’s potash imports from the North
prostate cancer treatment drug requirement, primarily in the form of Amalgamated Potash and Halite Block American nation fell 12.91% year-on-
muriate of potash (MOP) or potassium and the Jorkian-Satipura-Khunja Amal- year to Rs. 2,749.38-crore between
Zydus Lifesciences said it has and Drug Administration (USFDA) is to ed. Apalutamide is an androgen receptor chloride, from Canada, Russia, Turk- gamated Potash and Halite Block. Both April and December 2024. The short-
received fi nal approval from the US manufacture Apalutamide tablets of 60 inhibitor indicated for the treatment of menistan and Israel, among others, for are in Rajasthan. Bids are expected to fall was made good by Russia that
health regulator to manufacture a mg strength, Zydus Lifesciences said in patients with metastatic castration-sensi- fertiliser production. be in on May 1. Over 90% of potash is exported Rs. 3,145.99-crore worth
generic version of Apalutamide tab- a regulatory fi ling. The approved Apalu- tive prostate cancer. It had annual sales of used as fertiliser and is one of the three of the commodity in the same period,
lets used in the treatment of prostate tamide tablets will be produced at Zydus $1,099.8-mn in the US, the company said, “We will soon award India’s fi rst primary agricultural nutrients (nitrogen- up from Rs. 2,707.34-crore in April-
cancer. The approval by the US Food Lifesciences (SEZ), Ahmedabad, it add- citing IQVIA MAT January 2025 data. potash mine in Rajasthan...Once opera- phosphorus-potassium). December 2023.

150 Chemical Weekly April 1, 2025 Chemical Weekly April 1, 2025 151

Contents Index to Advertisers Index to Products Advertised